603707.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:00):

Stats
Dzisiejszy wolumen	20.01M
Średni wolumen	12.00M
Kapitalizacja rynkowa	21.04B
EPS	CNY0.131 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	20.68
ATR14	CNY0.0260 (0.20%)

Wolumen Korelacja

Długi: 0.16 (neutral)

Krótki: 0.45 (neutral)

Signal:(62.739) Neutral

Nanjing King-Friend Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanjing King-Friend Korelacja - Waluta/Towar

0.59
( weak )

0.51
( weak )

0.00
( neutral )

0.78
( moderate )

-0.33
( neutral )

-0.26
( neutral )

Nanjing King-Friend Finanse

Annual	2023
Przychody:	CNY3.88B
Zysk brutto:	CNY1.77B (45.77 %)
EPS:	CNY-0.120

FY	2023
Przychody:	CNY3.88B
Zysk brutto:	CNY1.77B (45.77 %)
EPS:	CNY-0.120

FY	2022
Przychody:	CNY3.71B
Zysk brutto:	CNY1.94B (52.38 %)
EPS:	CNY0.680

FY	2021
Przychody:	CNY3.69B
Zysk brutto:	CNY2.09B (56.71 %)
EPS:	CNY0.880

Financial Reports:

No articles found.

Nanjing King-Friend

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.